[1]
M. P. Kachhadia, “Disease-Modifying Therapies for Transthyretin Amyloid Cardiomyopathy: Current Evidence and Emerging Strategies”, J Clin Med Res, vol. 18, no. 7, pp. 421–436, Jan. 2026, doi: 10.14740/jocmr6603.